Hager Alicia J.
Insider CIK 1553354 · OMED VP & General Counsel · NKTX Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NKTX Nkarta, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 9,584 | $2.20 | $21.1K | 146,735 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2025-01-03 | 2025-01-07 | 105,000 | — | $0 | 105,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award | 2025-01-03 | 2025-01-07 | 52,500 | — | $0 | 156,319 | SEC↗ |
| NKTX Nkarta, Inc. | S Sale | 2024-07-16 | 2024-07-18 | 3,396 | $8.00 | $27.2K | 103,819 | SEC↗ |
| NKTX Nkarta, Inc. | S Sale | 2024-06-18 | 2024-06-20 | 727 | $5.60 | $4.1K | 107,215 | SEC↗ |
| NKTX Nkarta, Inc. | S Sale | 2024-01-16 | 2024-01-18 | 4,554 | $8.74 | $39.8K | 107,942 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2024-01-04 | 2024-01-08 | 112,500 | — | $0 | 112,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award | 2024-01-04 | 2024-01-08 | 56,000 | — | $0 | 112,496 | SEC↗ |
| NKTX Nkarta, Inc. | S Sale | 2023-06-20 | 2023-06-22 | 701 | $4.85 | $3.4K | 56,496 | SEC↗ |
| NKTX Nkarta, Inc. | S Sale | 2023-01-17 | 2023-01-18 | 1,103 | $5.49 | $6.1K | 57,197 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award | 2023-01-13 | 2023-01-18 | 37,500 | — | $0 | 58,300 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 50,500 | — | $0 | 50,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award | 2022-06-17 | 2022-06-21 | 8,000 | — | $0 | 20,800 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 76,800 | — | $0 | 76,800 | SEC↗ |
| NKTX Nkarta, Inc. | A Award | 2022-01-14 | 2022-01-19 | 12,800 | — | $0 | 12,800 | SEC↗ |
| NKTX | A Award deriv | 2021-01-08 | 2021-01-12 | 13,125 | — | $0 | 13,125 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-10-26 | 2020-10-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 39,488 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-10-10 | 2018-10-11 | 1,156 | $2.02 | $2.3K | 51,754 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-10-09 | 2018-10-10 | 1,686 | $2.13 | $3.6K | 52,910 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-04-24 | 2018-04-26 | 4,051 | $2.68 | $10.9K | 54,596 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-01-04 | 2018-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.26 | $196 | 59,849 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 58,647 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-10-07 | 2017-10-10 | 36,666 | — | $0 | 36,666 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-10-07 | 2017-10-10 | 18,334 | — | $0 | 59,895 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 41,561 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 32 | $8.87 | $284 | 25,845 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 4,284 | $9.06 | $38.8K | 21,561 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2017-03-15 | 2017-03-17 | 6,652 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2017-03-15 | 2017-03-17 | 6,652 | $3.42 | $22.7K | 32,529 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-03-15 | 2017-03-17 | 6,652 | $10.00 | $66.5K | 25,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-01-03 | 2017-01-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 25,877 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 13,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 1,570 | $22.30 | $35.0K | 13,430 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 52 | $21.54 | $1.1K | 13,378 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-12-27 | 2015-12-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-11-27 | 2015-12-01 | 1,800 | — | $0 | 6,652 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-11-27 | 2015-12-01 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-11-27 | 2015-12-01 | 1,800 | $23.14 | $41.7K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-10-27 | 2015-10-29 | 5,400 | — | $0 | 8,452 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-10-27 | 2015-10-29 | 5,400 | $21.00 | $113.4K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-10-27 | 2015-10-29 | 5,400 | $3.42 | $18.5K | 20,400 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-07-28 | 2015-07-29 | 1,800 | — | $0 | 13,852 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-07-28 | 2015-07-29 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-07-28 | 2015-07-29 | 1,800 | $21.00 | $37.8K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-06-29 | 2015-06-30 | 1,800 | — | $0 | 15,652 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-06-29 | 2015-06-30 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-06-29 | 2015-06-30 | 1,800 | $22.67 | $40.8K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-05-27 | 2015-05-28 | 1,800 | — | $0 | 17,452 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-05-27 | 2015-05-28 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-05-27 | 2015-05-28 | 1,800 | $23.07 | $41.5K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-04-27 | 2015-04-29 | 1,800 | — | $0 | 19,252 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-04-27 | 2015-04-29 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-27 | 2015-04-29 | 855 | $26.19 | $22.4K | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-27 | 2015-04-29 | 945 | $25.16 | $23.8K | 15,855 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-12-18 | 2014-12-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-07-17 | 2013-07-19 | 10,000 | — | $0 | 10,000 | SEC↗ |